Skip to search formSkip to main contentSkip to account menu

AZD2563

Known as: AZD 2563 
National Institutes of Health

Related topics

Related topics

3 relations

Narrower (1)

AZD5847

Broader (2)

OxazolidinonesPosizolid

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2011
Review
2011
The oxazolidinones: past, present, and future
The success of linezolid stimulated significant efforts to discover new agents in the oxazolidinone class. Over a dozen… 
2004
2004
AZD2563, a novel oxazolidinone: definition of antibacterial spectrum, assessment of bactericidal potential and the impact of miscellaneous factors on activity in vitro.
AZD2563, a new oxazolidinone targeted at Gram-positive bacteria, was evaluated and compared with linezolid and other agents… 
2003
2003
Activity of AZD2563, a Novel Oxazolidinone, against Staphylococcus aureus Strains with Reduced Susceptibility to Vancomycin or Linezolid
ABSTRACT The susceptibilities of clinical vancomycin-intermediate Staphylococcus aureus (VISA), heterogenous VISA, and laboratory… 
2003
2003
Activity of the oxazolidinones AZD2563 and linezolid against Corynebacterium jeikeium and other Corynebacterium spp.
Correspondence Activity of the oxazolidinones AZD2563 and linezolid against Corynebacterium jeikeium and other Corynebacterium… 
2002
2002
In vitro activity of AZD2563, a novel oxazolidinone, against European Gram-positive cocci.
AZD2563 is a new oxazolidinone that has targeted activity against Gram-positive bacteria. The in vitro activity of AZD2563 and… 
2002
2002
Anti-anaerobic activity of AZD2563, a new oxazolidinone, compared with eight other agents.
The anti-anaerobic activity of AZD2563, a new oxazolidinone, was compared with that of eight other agents against 201 Gram… 
2002
2002
In vitro activity of a novel oxazolidinone, AZD2563, against randomly selected and multiresistant Gram-positive cocci.
The in vitro activity of AZD2563, a novel oxazolidinone, was assessed against 595 Gram-positive cocci, comprising recent… 
2002
2002
Comparative Activities of the Oxazolidinone AZD2563 and Linezolid against Selected Recent North American Isolates of Streptococcus pneumoniae
ABSTRACT The activity of AZD2563 against 250 highly resistant pneumococci and 267 drug-susceptible isolates was determined. The… 
2002
2002
In Vitro Evaluation of AZD2563, a Novel Oxazolidinone, against 603 Recent Staphylococcal Isolates
ABSTRACT AZD2563, a novel oxazolidinone, and a selection of comparator drugs that included linezolid, erythromycin, clindamycin… 
2002
2002
In vitro evaluation of AZD2563, a new oxazolidinone, tested against beta-haemolytic and viridans group streptococci.
Linezolid was the first clinically applied agent from the oxazolidinone class, and AZD2563, a new agent, is described here. Five… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)